上海复旦张江生物医药股份有限公司于2026年3月2日发布最新股份变动月报表，报告期覆盖2026年2月。公告显示，期间公司注册股本及已发行股份均未发生变化，各类股本数量保持稳定。
报告期内，公司H股（股票代码：01349）已发行股份数维持在326,000,000股，A股（上海证券交易所科创板，代码：688505）已发行股份数仍为710,572,100股。公司注册股本总额截至2月底依旧为人民币103,657,210元，面值每股人民币0.1元。公告并无新增发行、股份购回或注销，以及期权激励等变动记录。
公司声明已遵守香港联交所《上市规则》有关公众持股量要求，并确认截至本月底符合相关规定。公告由公司秘书薛燕签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.